Fresh Day Meds
Fresh Day offers compounded GLP-1 and NAD+ injections. Its policies distinguish medical denial, voluntary withdrawal and unusually frequent GLP-1 renewal billing.
Review by Leah Garner, clinical-evidence editor · Updated October 2026
The short version
Useful care and fulfillment details are available, but the financial agreement needs close reading. The one-month GLP-1 label does not mean billing waits a calendar month.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Lowest listed: NAD+ injection, from $199/mo
Visit Fresh Day Meds →Fresh Day Meds arranges remote medical review and pharmacy fulfillment for several treatment categories. Its current peptide-related options include compounded semaglutide, tirzepatide and NAD+ injections. The site separates new-to-treatment and transfer plans, which matters because the starting regimen and longer-package price can differ. A transfer patient is asked to share an existing prescription label for clinical review. That is more specific than assuming a previous dose can simply continue unchanged. The provider still decides whether the treatment, format and strength are appropriate.
What Fresh Day Meds prescribes, by goal
Weight
- SemaglutideFDA-approved
- Injection (compounded)Price not published
- TirzepatideFDA-approved
- Injection (compounded)Price not published
The weight-management pages identify compounded preparations and distinguish them from the branded products cited in research. The published outcome figures should not be treated as a forecast for the compounded prescription or the individual patient. The clinician should explain the prescribed dose, concentration and administration instructions. New and transferring patients have different plan descriptions, so a headline should not determine the treatment pathway.
Longevity
- NAD+Compounding conditions apply
- Injection (compounded)From $199/mo
The NAD+ page expressly identifies compounded subcutaneous injections. It distinguishes a biological role for NAD+ from guaranteed clinical effects. A research figure about NAD+ precursors is also qualified as not being an outcome claim for the injectable product. That distinction is helpful. Ask what outcome the clinician proposes to assess and how treatment will be reviewed rather than assuming cellular-energy language guarantees improved symptoms.
Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.
Who prescribes
A licensed clinician
The legal pages identify a clinical network under the Telegra MD name. The terms refer to Telegra MD LLC, while the consent names Telegra MD Provider Network PC. Those documents should be read as identifying the clinical arrangements, rather than treating Fresh Day itself as the prescriber. Confirm the actual practice and assigned professional before accepting treatment. The consent permits remote evaluation through several forms of communication. It does not establish a guaranteed live appointment for every applicant. Ask who handles a clinically urgent question after the initial order is approved.
The process starts with an online assessment, followed by licensed-provider review and a prescription only when appropriate. The product pages describe ongoing follow-up access, while the transfer process requires information about existing treatment. Dose changes remain the provider’s decision. The service distinguishes clinical messages from routine subscription controls in the portal. That is useful, because stopping a future refill should not prevent someone from asking about side effects from a current prescription. Confirm the expected clinical response time and when a concern needs an in-person examination or other care outside the platform.
Are labs required?
Not mentioned
The expanded FAQ says the provider will explain when lab work is needed for a treatment plan. It specifically mentions testing for another treatment category, which does not establish a universal lab requirement for GLP-1 or NAD+ care. The public pages do not settle every possible testing charge. Ask what results are needed for the proposed prescription and whether recent outside results are accepted. Any abnormal finding needs a clear follow-up plan rather than simply another recurring order. A price that includes medical review is not automatically an unlimited testing allowance.
Ready to start with Fresh Day Meds?
Lowest listed price: NAD+ injection, from $199/mo. Confirm it on the seller’s own site.
What it claims, and what it cites
The site describes licensed US compounding pharmacies and states that the medicines are not FDA-approved. It also advertises independent business certification; that is different from regulatory approval of a medication. A particular dispensing pharmacy is not established by the general quality statements. Confirm the name and contact information for the actual order. Claims about included support are more useful when tied to clear instructions for treatment questions and delivery problems. The detailed cancellation policies are equally relevant to suitability, especially for a patient who may need to stop after a clinical concern.
How it bills
The one-month GLP-1 cards show $140 for semaglutide and $179 for tirzepatide. However, the subscription terms explicitly say those plans renew every 23 days; three-month GLP-1 plans renew every 83 days. Those are billing intervals, not merely shipping preparation dates. NAD+ has a separate $199 one-month plan and $477 three-month option. Initial medical ineligibility releases the payment hold without a consultation charge. Voluntary withdrawal after clinical work begins can instead incur $75. Future-refill cancellation does not reverse a paid order, and a renewal’s $75 consultation allocation is part of that payment rather than an extra charge. Confirm the accepted policy and next charge date.
LegitScript: seal displayed on the seller’s site
For and against
- For: New-patient and transfer pathways are described separately
- For: NAD research limitations are stated alongside promotional figures
- For: Clinical and payment policies distinguish different cancellation situations
- For: Provider support remains relevant even when future refills stop
- Against: GLP-1 billing occurs sooner than calendar-month wording suggests
- Against: A particular pharmacy is not established by general sourcing claims
- Against: Testing costs remain incompletely specified
- Against: Cancellation of future refills does not undo an order already in progress
The evidence behind what it sells
Right for
Someone comfortable with remote compounded care who can follow the exact billing schedule and distinguish a current order from future refills.
Look elsewhere if
A patient assuming monthly labels guarantee calendar-month charges or expecting a voluntary withdrawal to follow the same refund rule as medical denial.
Other sellers for weight
Sommar Club
Also prescribes Semaglutide, Tirzepatide.
Elara Health & Wellness
Also prescribes Semaglutide, Tirzepatide.
Calibrate
Also prescribes Semaglutide, Tirzepatide.
Fresh Day Meds
Frequently asked questions
- Are GLP-1 renewals just prepared early?
- The current subscription terms explicitly say the charge occurs every 23 days for one-month plans and every 83 days for three-month plans.
- Is $75 always added to a renewal?
- No. The policy describes it as an allocation within a successful renewal payment. A qualifying courtesy refund may retain it.
- Does stopping refills end access to clinical questions?
- The policy distinguishes refill cancellation from contacting the existing clinical team about side effects. Confirm the appropriate support channel.
Sources
- Care and treatment: Tirzepatide plans
- Care and treatment: Semaglutide product and administration
- Care and treatment: NAD prescription and plans
- Care and treatment: Current subscription billing rules
- Care and treatment: Payment and refund distinctions
- Care and treatment: Clinical and financial agreement
- Care and treatment: Independent care consent
- Care and treatment: Expanded public FAQ
See what Fresh Day Meds prescribes today
Fresh Day Meds sets its own prices, plans and the states it serves. Check them before you start.